AI-driven drug discovery firm Insilico bags $100m in fresh funding

AI-driven drug discovery firm Insilico bags $100m in fresh funding

Alex Zhavoronkov, founder and CEO of Hong Kong-based Insilico Medicine

Edited by: Padma Priya

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter